


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.33%
+6.42%
+14.96%
+3.68%
-0.28%
TEVA
Teva Pharma
$29.46
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
TEVA Price Performance
$34.41 (-14.39%)
$30.06 (-2.00%)
$19.42 (+51.70%)
$15.37 (+91.67%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
TEVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
TEVA has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 20, 2026
Upgrade
Buy
Zacks
Feb 04, 2026
Price Target Raised
Overweight
Barclays
Dec 30, 2025
Upgrade
BB
Dec 24, 2025
Upgrade
BB
S&P Global Ratings
Dec 23, 2025
Reiterate
Overweight
Piper Sandler
RPRX
Royalty Pharma plc
46.10
+0.99%
NVS
Novartis AG
154.87
+0.94%
REGN
Regeneron Pharmaceuticals
756.91
+1.49%
AZN
Astrazeneca
192.01
+1.11%
SNY
Sanofi
43.98
+0.87%
What is TEVA current stock price?
What are TEVA stock strengths?
What is TEVA Risk Level?
What is TEVA market cap and volume?
What is TEVA current Stock IQ?
Should I buy TEVA stock right now?
Is TEVA a Strong Buy right now?
What does a 'Strong Buy' rating mean for TEVA?
What does a 'Strong Sell' rating mean for TEVA?
What factors influence TEVA's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
TEVA
Teva Pharma
Current Price
$29.46
Runners Also Watch
RPRX
Royalty Pharma plc
46.10
+0.99%
NVS
Novartis AG
154.87
+0.94%
REGN
Regeneron Pharmaceuticals
756.91
+1.49%
AZN
Astrazeneca
192.01
+1.11%
SNY
Sanofi
43.98
+0.87%

TEVA Price Performance
$34.41 (-14.39%)
$30.06 (-2.00%)
$19.42 (+51.70%)
$15.37 (+91.67%)
TEVA Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
TEVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
TEVA has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
TEVA Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
TEVA Trading Signals
TEVA is trading 23.05% below analyst target price of $36.25, suggesting significant upside potential
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TEVA Stock trends
TEVA Stock performance
TEVA Stock analysis
TEVA investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.